A business in context

ELV research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-09-30 · 0001156039-26-000071

  2. 8-K · Current report

    Report date 2026-10-21 · 0001156039-26-000068 · Items 2.02,9.01

  3. 4 · Ownership change

    Report date 2026-10-02 · 0001748691-26-000005

  4. 8-K · Current report

    Report date 2026-09-10 · 0001156039-26-000063 · Items 7.01

  5. 4 · Ownership change

    Report date 2026-09-02 · 0002084548-26-000005

  6. 4 · Ownership change

    Report date 2026-09-02 · 0002084547-26-000009

  7. 4 · Ownership change

    Report date 2026-07-17 · 0001287920-26-000006

  8. 4 · Ownership change

    Report date 2026-07-17 · 0001192045-26-000004

  9. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001156039-26-000060

  10. 8-K · Current report

    Report date 2026-07-15 · 0001156039-26-000058 · Items 2.02,9.01

  11. 4 · Ownership change

    Report date 2026-06-12 · 0001659075-26-000006

  12. 4 · Ownership change

    Report date 2026-06-11 · 0001524849-26-000004

  13. 8-K · Current report

    Report date 2026-06-10 · 0001156039-26-000049 · Items 7.01

  14. 4 · Ownership change

    Report date 2026-05-19 · 0001659075-26-000004

  15. 8-K · Current report

    Report date 2026-05-13 · 0001156039-26-000046 · Items 5.07

  16. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001156039-26-000043

  17. 8-K · Current report

    Report date 2026-04-22 · 0001156039-26-000039 · Items 2.02,9.01

  18. DEF 14A · Proxy statement

    Report date 2026-05-13 · 0001156039-26-000031

  19. 8-K · Current report

    Report date 2026-03-10 · 0001156039-26-000024 · Items 7.01

  20. 8-K · Current report

    Report date 2026-03-02 · 0001156039-26-000022 · Items 8.01

  21. 8-K · Current report

    Report date 2026-02-26 · 0001156039-26-000019 · Items 5.02,7.01

  22. 10-K · Annual report

    Report date 2025-12-31 · 0001156039-26-000013

  23. 8-K · Current report

    Report date 2026-01-28 · 0001156039-26-000006 · Items 2.02,9.01

  24. 8-K · Current report

    Report date 2025-12-10 · 0001156039-25-000142 · Items 5.02

  25. 8-K · Current report

    Report date 2025-11-10 · 0001156039-25-000139 · Items 7.01

  26. 8-K · Current report

    Report date 2025-10-21 · 0001193125-25-244191 · Items 2.02,9.01

  27. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001156039-25-000136

  28. 8-K · Current report

    Report date 2025-09-08 · 0001193125-25-203542 · Items 8.01,9.01

  29. 8-K · Current report

    Report date 2025-09-04 · 0001156039-25-000129 · Items 7.01

  30. 8-K · Current report

    Report date 2025-07-28 · 0001156039-25-000118 · Items 5.02,9.01

  31. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001156039-25-000114

  32. 8-K · Current report

    Report date 2025-07-17 · 0001156039-25-000111 · Items 2.02,9.01

  33. 8-K · Current report

    Report date 2025-05-28 · 0001156039-25-000096 · Items 7.01

  34. 8-K · Current report

    Report date 2025-05-14 · 0001156039-25-000065 · Items 5.07

  35. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001156039-25-000057

  36. 8-K · Current report

    Report date 2025-04-22 · 0001156039-25-000056 · Items 2.02,9.01

  37. 8-K · Current report

    Report date 2025-04-17 · 0001156039-25-000051 · Items 2.02,7.01

  38. DEF 14A · Proxy statement

    Report date 2025-05-14 · 0001156039-25-000046

  39. 8-K · Current report

    Report date 2025-03-10 · 0001193125-25-050889 · Items 7.01

  40. 10-K · Annual report

    Report date 2024-12-31 · 0001156039-25-000010

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 3 transaction rows3PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 3 transaction rows3FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

6 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-03
2026-09-04
Wessling Erin MF · Tax / exercise payment
Disposed
Common Stock255.0414.78
2026-09-02
2026-09-04
Wessling Erin MF · Tax / exercise payment
Disposed
Common Stock94.0405.84
2026-09-02
2026-09-04
Craig Ryan RF · Tax / exercise payment
Disposed
Common Stock144.0405.84
2026-07-17
2026-07-17
BOUDREAUX GAILP · Purchase
Acquired
Common Stock680.0366.41
2026-07-17
2026-07-17
BOUDREAUX GAILP · Purchase
Acquired
Common Stock2045.0368.25
2026-07-17
2026-07-17
PERU RAMIRO GP · Purchase
Acquired
Common Stock1000.0366.05

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001156039Elevance Health, Inc.
Carelon

Showing 1 of 1 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
8MYN82XMYQH89CTMTH67
GLEIF legal name
ELEVANCE HEALTH, INC.
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2026-02-17T12:25:04Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • WellPoint, Inc · alias · wikidata
  • Anthem · alias · wikidata
  • Anthem Blue Cross and Blue Shield · alias · wikidata
  • Anthem Insurance Companies · alias · wikidata
  • Anthem, Inc. · alias · wikidata
  • Anthem Inc. · alias · wikidata
  • Carelon · subsidiary · wikidata
  • Anthem, Inc. · former SEC name · 2014-12-02 to 2022-06-24
  • WELLPOINT, INC · former SEC name · 2010-01-06 to 2014-11-12
  • WELLPOINT INC · former SEC name · 2004-11-30 to 2009-12-21
  • ANTHEM INC · former SEC name · 2001-12-17 to 2004-11-30
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$177.01B$190.13B
2023-12-31$171.34B$189.46B
2022-12-31$156.59B$180.26B
2021-12-31$138.64B$172.36B
2020-12-31$121.87B$158.65B
2019-12-31$104.21B$137.34B
2018-12-31$92.11B$123.58B
2017-12-31$90.04B$123.77B

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗